Clinical Trials Browser

Phase 1/2 × Radiodermatitis × 90 days × Clear all

NCT05269160 2026-02-17

Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)

Phase 1/2 Terminated

3 enrolled 8 charts

Breast Neoplasms, Radiodermatitis